HighTower Advisors
CNSY icon

HighTower Advisors’s Cerenome CNSY Stock Holding History

HighTower Advisors’s Portfolio CNSY Stock Details CNSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-640
Closed -$8.2K – 3905
2025
Q4 		$8.2K Buy
+640
New +$9.7K ﹤0.01% 3639
2018
Q2 		– Hold
0
– -$5K – 2357
2018
Q1 		– Hold
0
– – – 2121
2017
Q4 		– Hold
0
– – – 2209
2017
Q3 		– Hold
0
– – – 2164
2017
Q2 		– Hold
0
– – – 2083
2017
Q1 		– Hold
0
– – – 1958

Other funds holding CNSY

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Two Sigma Securities
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
XTX Topco
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

HighTower Advisors's CNSY Position: Q1 2026 in Review

HighTower Advisors sold out of Cerenome (CNSY) in Q1 2026, closing a stake of 640 shares — an estimated $8.2K sold.

HighTower Advisors first reported a position in CNSY in Q4 2025 and held it in 1 quarter. The position peaked at $8.2K in Q4 2025. 23 funds tracked by Wall St. Rank hold CNSY as of Q1 2026.

  • HighTower Advisors reported no remaining Cerenome position as of Q1 2026 after selling out during the quarter.
  • HighTower Advisors sold 640 Cerenome shares in Q1 2026, an estimated $8.2K.
  • HighTower Advisors first reported a position in Cerenome in Q4 2025 and held it in 1 quarter.
  • HighTower Advisors's Cerenome position peaked at $8.2K in Q4 2025.
  • 23 funds tracked by Wall St. Rank held Cerenome as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.